>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Alibaba (BABA) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $180
    • Amneal Pharmaceuticals (AMRX) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $12
    • Bath & Body Works (BBWI) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $43
    • Block (XYZ) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt lowered to $89
    • Bluebirdbio (BLUE) upgraded to Neutral from Underweight at JP Morgan
    • Carrier Global (CARR) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $80
    • Century Aluminum (CENX) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt $22
    • CF Industries (CF) upgraded to Neutral from Underperform at BofA Securities; tgt $84
    • ESAB Corp. (ESAB) upgraded to In-line from Underperform at Evercore ISI; tgt lowered to $120
    • Floor & Decor (FND) upgraded to Buy from Hold at Stifel; tgt raised to $110
    • Freshpet (FRPT) upgraded to Buy from Hold at Jefferies; tgt lowered to $150
    • Janus Henderson Group (JHG) upgraded to Buy from Neutral at UBS; tgt raised to $50
    • NIKE (NKE) upgraded to Buy from Hold at Jefferies; tgt raised to $115
    • NMI Hldgs (NMIH) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt $43
    • Old Dominion (ODFL) upgraded to Buy from Hold at Stifel; tgt raised to $200
    • RTX (RTX) upgraded to Buy from Neutral at UBS; tgt $147
    • Saia (SAIA) upgraded to Buy from Hold at Stifel; tgt $524
    • Select Medical (SEM) upgraded to Buy from Hold at The Benchmark Company; tgt $23
    • Transdigm Group (TDG) upgraded to Buy from Neutral at UBS; tgt $1595
    • Twilio (TWLO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $160
    • Wingstop (WING) upgraded to Buy from Neutral at Guggenheim; tgt $280
    • XPeng (XPEV) upgraded to Neutral from Sell at UBS; tgt raised to $18
    • XPO, Inc. (XPO) upgraded to Buy from Hold at Stifel; tgt $147
  • Downgrades:
    • Arbor Realty Trust (ABR) downgraded to Mkt Perform from Outperform at Raymond James
    • Conagra (CAG) downgraded to Neutral from Buy at Goldman; tgt lowered to $26
    • Exelixis (EXEL) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $36
    • Ferroglobe PLC (GSM) downgraded to Neutral from Buy at Seaport Research Partners
    • GDS Holdings (GDS) downgraded to Hold from Buy at Jefferies; tgt raised to $45
    • Intra-Cellular Therapies (ITCI) downgraded to Neutral from Outperform at Mizuho; tgt lowered to $132
    • Lucid Group (LCID) downgraded to Sell from Neutral at Redburn Atlantic; tgt lowered to $1.13
    • Nordson (NDSN) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $219
    • Rivian Automotive (RIVN) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $10
  • Others:
    • Agios Pharma (AGIO) initiated with a Buy at H.C. Wainwright; tgt $58
    • Aramark (ARMK) resumed with a Buy at Citigroup; tgt $48
    • Beta Bionics (BBNX) initiated with an Outperform at Leerink Partners; tgt $28
    • Beta Bionics (BBNX) initiated with an Overweight at Piper Sandler; tgt $26
    • Beta Bionics (BBNX) initiated with a Buy at Stifel; tgt $25
    • Blue Owl Capital (OWL) initiated with an Overweight at Barclays; tgt $29
    • Boyd Gaming (BYD) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $81
    • Cintas (CTAS) resumed with a Sell at Citigroup; tgt $161
    • Compass Therapeutics (CMPX) initiated with a Buy at Guggenheim; tgt $12
    • Intercontinental Hotels Group (IHG) resumed with a Sell at Citigroup
    • Kimbell Royalty Partners (KRP) initiated with a Buy at Texas Capital